Levels of Murine, but Not Human, CXCL13 Are Greatly Elevated in NOD-SCID Mice Bearing the AIDS-Associated Burkitt Lymphoma Cell Line, 2F7
Open Access
- 2 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e72414
Abstract
Currently, few rodent models of AIDS-associated non-Hodgkin’s lymphoma (AIDS-NHL) exist. In these studies, a novel mouse/human xenograft model of AIDS-associated Burkitt lymphoma (AIDS-BL) was created by injecting cells of the human AIDS-BL cell line, 2F7, intraperitoneally into NOD-SCID mice. Mice developed tumors in the peritoneal cavity, with metastases to the spleen, thymus, and mesenteric lymph nodes. Expression of the chemokine receptor, CXCR5, was greatly elevated in vivo on BL tumor cells in this model, as shown by flow cytometry. CXCL13 is the ligand for CXCR5, and serum and ascites levels of murine, but not human, CXCL13 showed a striking elevation in tumor-bearing mice, with levels as high as 200,000 pg/ml in ascites, as measured by ELISA. As shown by immunohistochemistry, murine CXCL13 was associated with macrophage-like tumor-infiltrating cells that appeared to be histiocytes. Blocking CXCR5 on 2F7 cells with neutralizing antibodies prior to injection into the mice substantially delayed tumor formation. The marked elevations in tumor cell CXCR5 expression and in murine CXCL13 levels seen in the model may potentially identify an important link between tumor-interacting histiocytes and tumor cells in AIDS-BL. These results also identify CXCL13 as a potential biomarker for this disease, which is consistent with previous studies showing that serum levels of CXCL13 were elevated in human subjects who developed AIDS-lymphoma. This mouse model may be useful for future studies on the interactions of the innate immune system and AIDS-BL tumor cells, as well as for the assessment of potential tumor biomarkers for this disease.Keywords
This publication has 36 references indexed in Scilit:
- Clues Emerge on How HIV Increases Lymphoma RiskJNCI: Journal of the National Cancer Institute, 2010
- Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's LymphomaAIDS Research and Treatment, 2010
- The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphomaJournal of Leukocyte Biology, 2009
- Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell LymphomasJournal of Nuclear Medicine, 2009
- Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infectionBlood, 2008
- HIV infection and lymphomaJournal of Clinical Pathology, 2007
- B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissueArthritis Research & Therapy, 2007
- RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitizationJournal of Leukocyte Biology, 2006
- Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomasBlood, 2004
- SIV-associated Lymphomas in Rhesus Monkeys (Macaca mulatta) in Comparison with HIV-associated LymphomasVeterinary Pathology, 2002